Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol ... According to Chipps, the data from the meta-analysis will be used to inform an upcoming asthma guideline from the Joint Task ...

New research from the University of Pittsburgh uncovers how inhaled house dust mites, a common trigger of allergic asthma, ...

looking for incidents of asthma attacks. They also tracked each patients' use of various diabetes medications. Data was ...

"Metformin was associated with a lowered risk of asthma attacks by approximately 30%," the researchers found. When patients ...

Evidence supports the use of inhaled corticosteroids (ICS) + fast-acting bronchodilator treatments when used as needed in response to symptoms to improve asthma control and reduce rates of ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.